Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03598816
What this trial is testing

PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Washington University School of Medicine
Early research (Phase 1)Ended earlyNCT00520533
What this trial is testing

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Ludwig Institute for Cancer Research 8
Not applicableStudy completedNCT01107509
What this trial is testing

Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers

Who this might be right for
Carcinoma, Renal Cell
St. Joseph's Healthcare Hamilton 20
Not applicableStudy completedNCT04637204
What this trial is testing

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Who this might be right for
Renal Cell Carcinoma
Ipsen 1,540
Early research (Phase 1)Study completedNCT03829111
What this trial is testing

CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaClear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma+3 more
City of Hope Medical Center 30
Testing effectiveness (Phase 2)WithdrawnNCT01176500
What this trial is testing

A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors

Who this might be right for
Colon CancerLung CancerCervical Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT00030888
What this trial is testing

UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of California, San Francisco
Not applicableUnknownNCT05534854
What this trial is testing

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

Who this might be right for
Renal Tumor HistologyKidney CancerRenal Cell Carcinoma+11 more
RenJi Hospital 500
Large-scale testing (Phase 3)Active Not RecruitingNCT03055013
What this trial is testing

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

Who this might be right for
Metastatic Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v7+2 more
National Cancer Institute (NCI) 819
Not applicableStudy completedNCT00957424
What this trial is testing

Acceptability of Less Harmful Alternatives to Cigarettes

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 67
Early research (Phase 1)Active Not RecruitingNCT02293980
What this trial is testing

A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)

Who this might be right for
ccRCCRCCKidney Cancer+2 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 110
Testing effectiveness (Phase 2)WithdrawnNCT01070186
What this trial is testing

Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Jonsson Comprehensive Cancer Center
Not applicableNot Yet RecruitingNCT05941169
What this trial is testing

Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy

Who this might be right for
Renal Cell Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 750
Testing effectiveness (Phase 2)Study completedNCT00054886
What this trial is testing

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Neoplasms
Pfizer 63
Testing effectiveness (Phase 2)Study completedNCT00006483
What this trial is testing

Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

Who this might be right for
Kidney CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 27
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Not applicableStudy completedNCT04472663
What this trial is testing

Participant Reported Outcomes and Treatment Experiences in Kidney Cancer

Who this might be right for
Kidney Cancer
Bristol-Myers Squibb 5
Testing effectiveness (Phase 2)UnknownNCT01791387
What this trial is testing

1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Auckland District Health Board 30
Testing effectiveness (Phase 2)UnknownNCT05798455
What this trial is testing

Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Tabriz University of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT01157091
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage IV Renal Cell Cancer
City of Hope Medical Center 28
Next Page